• Medientyp: E-Artikel
  • Titel: Age-Related Changes in a Patient With Pelizaeus-Merzbacher Disease Determined by Repeated 1H-Magnetic Resonance Spectroscopy
  • Beteiligte: Mori, Tatsuo; Mori, Kenji; Ito, Hiromichi; Goji, Aya; Miyazaki, Masahito; Harada, Masafumi; Kurosawa, Kenji; Kagami, Shoji
  • Erschienen: SAGE Publications, 2014
  • Erschienen in: Journal of Child Neurology
  • Sprache: Englisch
  • DOI: 10.1177/0883073813499635
  • ISSN: 0883-0738; 1708-8283
  • Schlagwörter: Neurology (clinical) ; Pediatrics, Perinatology and Child Health
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:p> A boy with Pelizaeus-Merzbacher disease underwent repeated evaluations by 3-Tesla <jats:sup>1</jats:sup>H-magnetic resonance spectroscopy (MRS). The patient showed overlap of the PLP1. Individuals selected as normal controls for <jats:sup>1</jats:sup>H-magnetic resonance spectroscopy consisted of healthy age-matched children. For <jats:sup>1</jats:sup>H-magnetic resonance spectroscopy, the center of a voxel was positioned in the right parietal lobe. <jats:sup>1</jats:sup>H-magnetic resonance spectroscopy was performed when the patient was 2, 6, 14, and 25 months old. γ-Aminobutyric acid concentration in early childhood was increased compared with that in normal controls. However, the γ-aminobutyric acid concentration in the Pelizaeus-Merzbacher disease patient was normalized at 14 and 25 months. No remarkable changes were observed in choline-containing compounds concentration at any time. These results suggest that the changes in metabolite concentrations during growth can reflect the pathological condition of Pelizaeus-Merzbacher disease. Furthermore, the lack of change in the choline-containing compounds concentration can be useful for differentiating Pelizaeus-Merzbacher disease from other white matter disorders. </jats:p>